Literature DB >> 2207606

Factors affecting the outcome of assisted conception.

I Craft1.   

Abstract

In order to assess the major biological and clinical factors which influence the outcome of both IVF and GIFT, the results of a large GIFT series performed in this unit have been analysed over a time interval when two different policies have been in force as to the number of oocytes that should be transferred. The reason for using GIFT data, as opposed to IVF, is simply because it is more difficult to adversely affect the outcome of GIFT treatment, as opposed to IVF, and hence this allows more critical appraisal and interpretation of results. The GIFT series to be described was conducted between March 1986 and October 1987, when a flexible policy on the number of oocytes for transfer was in operation. Since then a fixed policy has been in force at the request of the Hospital's Ethics Committee and the Voluntary Licensing Authority (now the Interim Licensing Authority), whereby three, or exceptionally four, oocytes are transferred irrespective of individual patient's circumstances because of concern about the relative risk and sequelae of multiple pregnancy and selective reduction of pregnancy. I still believe, however, that some infertile couples have a lower chance of pregnancy with assisted, or natural conception and also a lower risk of multiple pregnancy and that it is therefore important to assess the biological and clinical factors influencing fecundity in order to formulate appropriate treatment policies.

Entities:  

Mesh:

Year:  1990        PMID: 2207606     DOI: 10.1093/oxfordjournals.bmb.a072430

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  4 in total

1.  IVF versus GIFT.

Authors:  I Craft; T al-Shawaf
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Limiting the number of oocytes and embryos transferred in GIFT and IVF.

Authors:  I Craft; T al-Shawaf
Journal:  BMJ       Date:  1991-07-20

3.  A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.

Authors:  S Bassil; C Wyns; J Donnez
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

4.  A double-blind randomized controlled trial investigating a time-lapse algorithm for selecting Day 5 blastocysts for transfer.

Authors:  Aisling Ahlström; Kersti Lundin; Anna-Karin Lind; Kristina Gunnarsson; Göran Westlander; Hannah Park; Anna Thurin-Kjellberg; Steinunn A Thorsteinsdottir; Snorri Einarsson; Mari Åström; Kristina Löfdahl; Judith Menezes; Susanne Callender; Cina Nyberg; Jens Winerdal; Camilla Stenfelt; Brit-Randi Jonassen; Nan Oldereid; Lisa Nolte; Malin Sundler; Thorir Hardarson
Journal:  Hum Reprod       Date:  2022-04-01       Impact factor: 6.353

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.